Home

 01/02/2025 We are excited to announce that our Melanocyte Stimulating Hormone, Alpha (a-MSH) is now NYS DOH Approved tests PFI#9065

 

We have launched a client web portal to review results and pendings on LabNexus. Please visit the link below and contact ISI to create an account:

https://interscience.labnexus.net/

Neuroendocrine Tumor (NETs) Diagnostic Testing

Providing continuity of service for rare Endocrinology and Gastroenterology testing since 1969
is still the hallmark of Inter Science Institute.

Read more about these conclusions about ISI’s Pancreastatin assay providing valuable information for patients at high risk of recurrence and accurately detecting progression.

Diabesity Related Testing

In addition to being in the forefront of NETs testing, ISI is proud to offer a wide range of testing to provide physicians and researchers critical diagnostic and monitoring tools in the field of obesity and diabetes. Our menu includes:

  • Ghrelin
  • GLP_1 
  • NPY
  • CCK
  • AgRP
  • PYY
  • Melanocyte Stimulating Hormone, Alpha (a-MSH)

Please contact us (requests@interscienceinstitute.com) if you need additional information about these tests. 

5-HIAA assay is now available on plasma EDTA or (Z-tubeTM) from ISI

New test available for patients: the 5-HIAA assay is now available on plasma EDTA or (Z-tubeTM) from ISI. Click here to see the requirements

New Assays Now Available

Our specialized Melanocyte Stimulating Hormone, Alpha (α-MSH) test is now NYS DOH approved (PFI#9065), validated for clinical use in metabolic and endocrine assessment

GLP-1 Assay: Now fully validated for clinical use

Our GLP-1 test is now fully validated for clinical use, supporting metabolic and endocrine evaluations and aligning with ongoing clinical trials in obesity, diabetes, and incretin-based therapeutic research

Now Validated: Glucagon Testing for Clinical and Research Use

Our Glucagon assay is fully validated for clinical use, aiding metabolic and endocrine evaluations, and supporting ongoing clinical trials in diabetes, hypoglycemia, and glucagon-targeted therapies.

ISI's Latest Journal Publications are Available

C.U.R.E.® Catalogue

The C.U.R.E.® Catalogue lists over 150 individual assays, that can be performed on plasma/serum, urine, CSF, Saliva, and other fluids in the areas of:

  • G.I. & Pancreatic Tests
  • Hypertension, Corticosteroid, & Mineralocorticoid Tests
  • Hypothalamic-pituitary Axis & Releasing Factor Tests
  • Multi-disciplinary Tests Pediatric & Enzyme Deficiency Tests
  • Reproductive Endocrinology & Gonadal
  • Steroid Tests
  • Thyroid Tests

Please contact ISI for the most up-to-date testing availability.

Search Individual Assays

For the Most Recent Edition of the C.U.R.E.® (Current Unique and Rare Endocrine) Catalogue please contact the Institute at: requests@interscienceinstitute.com

ISI is the leader in neuroendocrine tumors (NET's) Biomarker Testing

Updated with ICD-10 codes

Since 1969, our cutting-edge esoteric services to the medical, research, and academic communities, Inter Science Institute specializes in research and development emphasis in the area of Neuroendocrine Tumors (NET’s). The current 5th edition handbook, Neuroendocrine Tumors: A Comprehensive Guide to Diagnosis and Management, is available for download on this website or by contacting ISI at requests@interscienceinstitute.com.

Click here for the previous edition.

Subscribe to Other

Integer at rhoncus nulla, quis molestie justo. Maecenas congue, magna vitae gravida viverra, odio lacus pharetra urna, eget porttitor ex tortor eget risus.

Subscribe to
Inflammation markers

Integer at rhoncus nulla, quis molestie justo. Maecenas congue, magna vitae gravida viverra, odio lacus pharetra urna, eget porttitor ex tortor eget risus.

Subscribe to Diabesity

Integer at rhoncus nulla, quis molestie justo. Maecenas congue, magna vitae gravida viverra, odio lacus pharetra urna, eget porttitor ex tortor eget risus.

Subscribe to
Neuroendocrine Tumor (NETs)

Integer at rhoncus nulla, quis molestie justo. Maecenas congue, magna vitae gravida viverra, odio lacus pharetra urna, eget porttitor ex tortor eget risus.

Join Us

Subscribe to our mailing list to stay informed on the latest articles and new services.